Classifying PML risk with disease modifying therapies

Berger, JR

Berger, JR (reprint author), Univ Penn, Perelman Sch Med, Dept Neurol, 3400 Spruce St,Gates 3W, Philadelphia, PA 19104 USA.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017; 12 ( ): 59

Abstract

Objective: To catalogue the risk of PML with the currently available disease modifying therapies (DMTs) for multiple sclerosis ( MS). Background: All ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索